U.S. markets open in 8 hours 59 minutes
  • S&P Futures

    3,754.00
    -11.50 (-0.31%)
     
  • Dow Futures

    30,788.00
    -90.00 (-0.29%)
     
  • Nasdaq Futures

    12,401.75
    -53.25 (-0.43%)
     
  • Russell 2000 Futures

    2,134.80
    -9.70 (-0.45%)
     
  • Crude Oil

    64.31
    +0.48 (+0.75%)
     
  • Gold

    1,689.60
    -11.10 (-0.65%)
     
  • Silver

    25.23
    -0.24 (-0.93%)
     
  • EUR/USD

    1.1963
    -0.0016 (-0.13%)
     
  • 10-Yr Bond

    1.5500
    -1.4700 (-100.00%)
     
  • Vix

    28.57
    -26.67 (-100.00%)
     
  • GBP/USD

    1.3885
    -0.0009 (-0.07%)
     
  • USD/JPY

    108.0380
    +0.0620 (+0.06%)
     
  • BTC-USD

    46,967.36
    -2,707.09 (-5.45%)
     
  • CMC Crypto 200

    938.45
    -48.76 (-4.94%)
     
  • FTSE 100

    6,650.88
    -24.59 (-0.37%)
     
  • Nikkei 225

    28,639.83
    -290.28 (-1.00%)
     

INVESTOR ALERT: Monteverde & Associates Continues to Investigate the Following Merger

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / February 5, 2021 /Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating:

  • NantKwest, Inc. (NASDAQ:NK) relating to its proposed merger with ImmunityBio. Under the terms of the agreement, ImmunityBio shareholders will receive 0.8190 shares of NatKwest per share they own. Click here for more information: https://www.monteverdelaw.com/case/nantkwest-inc. It is free and there is no cost or obligation to you.

  • Magellan Health, Inc. (NASDAQ:MGLN) relating to its proposed acquisition by Centene Corporation. Under the terms of the agreement, MGLN shareholders will receive $95.00 in cash per share. Click here for more information: https://www.monteverdelaw.com/case/magellan-health-inc. It is free and there is no cost or obligation to you.

  • National Holdings Corporation (NASDAQ:NHLD) relating to its proposed acquisition by B. Riley Financial, Inc. Under the terms of the tender offer, NHLD shareholders will receive $3.25 in cash per share they own. Click here for more information: https://www.monteverdelaw.com/case/national-holdings-corporation. It is free and there is no cost or obligation to you.

About Monteverde & Associates PC
We are a national class action securities litigation law firm that has recovered millions of dollars and is committed to protecting shareholders from corporate wrongdoing. We were listed in the Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report. Our lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions. Mr. Monteverde is recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019, an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017-2019 Top Rated Lawyer. Our firm's recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019). Also, in 2019 we recovered or secured six cash common funds for shareholders in mergers & acquisitions class action cases.

If you own common stock in any of the above listed companies and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341

Attorney Advertising. (C) 2021 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.

SOURCE: Monteverde & Associates PC



View source version on accesswire.com:
https://www.accesswire.com/628182/INVESTOR-ALERT-Monteverde-Associates-Continues-to-Investigate-the-Following-Merger